What we're reading, February 12, 2016: the former Kentucky governor is looking to block the current governor's plans to dismantle Kynect; Senator Orrin Hatch speaks out against Medicare negotiation of drug prices; and the link between Zika and microcephaly is growing stronger.
In Kentucky, the former governor, Steve Beshear, is launching an effort to thwart the efforts of the new Republican governor, Matt Bevin, who is starting the process to dismantle the state’s health insurance exchange, Kynect. Beshear announced that an online campaign will educate voters about what is happening to healthcare in Kentucky, according to ABC News. During Beshear’s time as governor, he issued an executive order to expand Medicaid and establish the state exchange.
While some presidential hopefuls, like Hillary Clinton, Bernie Sanders, and Donald Trump, are calling for Medicare to have the ability to negotiate drug prices, Senator Orrin Hatch is firmly against it, noting that Medicare negotiation wouldn’t be “a big saver.” Washington Examiner reported that the senator asked HHS Secretary Sylvia M. Burwell if her agency had worked with the president on an executive order that would allow the government to negotiate prices. Hatch is worried the president would issue such an executive order, which Hatch called a “violation of the law.”
The link between the Zika virus and microcephaly is growing stronger, CDC Director Tom Frieden, MD, testified before the Senate Appropriations Committee. Studies of babies that died within 24 hours found they had microcephaly, according to the Washington Times. Dr Frieden and Anthony Fauci, MD, infectious disease director at the National Institutes of Health, asked lawmakers to approve the president’s request for emergency funding to fight Zika.
Trump Administration’s Message to Supreme Court Puts New Wrinkle in Braidwood Case
February 21st 2025The Trump administration argues that HHS Secretary Robert F. Kennedy Jr can overrule the US Preventive Services Task Force to determine the preventive services covered under the Affordable Care Act.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
Insurance Payer Is Associated With Length of Stay After Traumatic Brain Injury
February 21st 2025Among hospitalized patients with traumatic brain injury, Medicaid fee-for-service was associated with longer hospital stays than private insurance and Medicaid managed care organizations.
Read More
NSCLC Advancements Offer Hope, but Disparities Persist
February 20th 2025Ioana Bonta, MD, Georgia Cancer Specialists, discusses the evolving state of non-small cell lung cancer (NSCLC) treatments, their impact on patient outcomes, and the need to address ongoing disparities in these populations.
Read More